Advanced Search

Study Preview



Study Title and Description

Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects.



Key Questions Addressed
1 Is this a fiber intervention study?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects.
Author Juvonen KR., Salmenkallio-Marttila M., Lyly M., Liukkonen KH., Lähteenmäki L., Laaksonen DE., Uusitupa MI., Herzig KH., Poutanen KS., Karhunen LJ.
Country Food and Health Research Centre, Department of Clinical Nutrition, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland. kristiina.juvonen@uef.fi
Year 2011
Numbers Pubmed ID: 20605427

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Fiber Database
Arms
No arms have been defined in this extraction form.

Design Details
Question... Follow Up Answer Follow-up Answer
Year of Publication 2011
  • Comments Comments (
    0
    ) |
Country of Publication Finland
  • Comments Comments (
    0
    ) |
What was the study design? Randomized Controlled Trial (Crossover)
  • Comments Comments (
    0
    ) |
Was the study blinded? single blind
  • Comments Comments (
    0
    ) |
Study diet type acute feeding study
  • Comments Comments (
    0
    ) |
Level of feeding control for dietary intervention All food provided
  • Comments Comments (
    0
    ) |
Sample size 20
  • Comments Comments (
    0
    ) |
Is there a run-in period? No
  • Comments Comments (
    0
    ) |
Is there a washout period? Yes
  • Comments Comments (
    0
    ) |
Did the administered fiber dose change over the course of the study? No
  • Comments Comments (
    0
    ) |
What is the age of the population (categorical)? Adults (20+ Years); Adolescents (12-19 Years)
  • Comments Comments (
    0
    ) |
Study population, mean age in years 23.3
  • Comments Comments (
    0
    ) |
Study population, age range in years 19-33
  • Comments Comments (
    0
    ) |
Study Population, mean BMI, kg/m2 21.7
  • Comments Comments (
    0
    ) |
Study population, BMI Range, kg/m2 19.1-24.8
  • Comments Comments (
    0
    ) |
Baseline health status Healthy
  • Comments Comments (
    0
    ) |
Gender (% male) ~25
  • Comments Comments (
    0
    ) |
Fiber 1-type Wheat Bran
  • Comments Comments (
    0
    ) |
Fiber 1-if combination was selected for fiber type, 1st fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 1-if combination was selected for fiber type, 2nd fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 1- dose 1 (g) 10
  • Comments Comments (
    0
    ) |
Fiber 1- dose 2 (g) -
  • Comments Comments (
    0
    ) |
Fiber 1-Duration of intervention ~24 hours
  • Comments Comments (
    0
    ) |
Fiber 1-how was the fiber administered? Test Meal
  • Comments Comments (
    0
    ) |
Fiber 2-type Oat Bran
  • Comments Comments (
    0
    ) |
Fiber 2-if combination was selected for fiber type, 1st fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 2-if combination was selected for fiber type, 2nd fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 2- dose 1 (g) 10
  • Comments Comments (
    0
    ) |
Fiber 2- dose 2 (g) -
  • Comments Comments (
    0
    ) |
Fiber 2-Duration of intervention ~24 hours
  • Comments Comments (
    0
    ) |
Fiber 2-how was the fiber administered? Test Meal
  • Comments Comments (
    0
    ) |
Fiber 3-type Combination/Mixture
  • Comments Comments (
    0
    ) |
Fiber 3-if combination was selected for fiber type, 1st fiber type in combination wheat bran
  • Comments Comments (
    0
    ) |
Fiber 3-if combination was selected for fiber type, 2nd fiber type in combination oat bran
  • Comments Comments (
    0
    ) |
Fiber 3- dose 1 (g) 5
  • Comments Comments (
    0
    ) |
Fiber 3- dose 2 (g) 5
  • Comments Comments (
    0
    ) |
Fiber 3-Duration of intervention ~24 hours
  • Comments Comments (
    0
    ) |
Fiber 3-how was the fiber administered? Test Meal
  • Comments Comments (
    0
    ) |
Fiber 4-type -
  • Comments Comments (
    0
    ) |
Fiber 4-if combination was selected for fiber type, 1st fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 4-if combination was selected for fiber type, 2nd fiber type in combination -
  • Comments Comments (
    0
    ) |
Fiber 4- dose 1 (g) -
  • Comments Comments (
    0
    ) |
Fiber 4- dose 2 (g) -
  • Comments Comments (
    0
    ) |
Fiber 4-Duration of intervention -
  • Comments Comments (
    0
    ) |
Fiber 4-how was the fiber administered? -
  • Comments Comments (
    0
    ) |
Comparator 1- what was the comparator used in the intervention? Control
  • Comments Comments (
    0
    ) |
Comparator 1-dose 0
  • Comments Comments (
    0
    ) |
Comparator 1-duration of comparator intervention ~24 hours
  • Comments Comments (
    0
    ) |
Comparator 1-how was the comparator administered to participants? Test Meal
  • Comments Comments (
    0
    ) |
Comparator 2- what was the comparator used in the intervention? -
  • Comments Comments (
    0
    ) |
Comparator 2-dose -
  • Comments Comments (
    0
    ) |
Comparator 2-duration of comparator intervention -
  • Comments Comments (
    0
    ) |
Comparator 2-how was the comparator administered to participants? -
  • Comments Comments (
    0
    ) |
Comparator 3- what was the comparator used in the intervention? -
  • Comments Comments (
    0
    ) |
Comparator 3-dose -
  • Comments Comments (
    0
    ) |
Comparator 3-duration of comparator intervention -
  • Comments Comments (
    0
    ) |
Comparator 3-how was the comparator administered to participants? -
  • Comments Comments (
    0
    ) |
Comparator 4- what was the comparator used in the intervention? -
  • Comments Comments (
    0
    ) |
Comparator 4-dose -
  • Comments Comments (
    0
    ) |
Comparator 4-duration of comparator intervention -
  • Comments Comments (
    0
    ) |
Comparator 4-how was the comparator administered to participants? -
  • Comments Comments (
    0
    ) |


Baseline Characteristics
No baseline characteristics have been defined for this extraction form.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Comments

Quality Dimensions
No quality dimensions were specified.

Quality Rating
No quality rating data was found.